title: Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes.
abstract: The addition of the dipeptidyl peptidase-4 (DDP-4) inhibitor has been reported to achieve greater improvements in glucose metabolism with fewer adverse events compared to increasing the metformin dose in type 2 diabetic patients. We present a patient with steroid-induced diabetes whose blood glucose levels were ameliorated by the use of the DPP-4 inhibitor, showing that the DPP-4 inhibitors may be an effective and safe oral anti-diabetic drug for steroid-induced diabetes.
authors.affiliation: Hidekatsu Yanai, Yoshinori Masui, Reo Yoshikawa, Junwa Kunimatsu, Department of Internal Medicine, Kohnodai Hospital, National Center for Global Health and Medicine, Chiba 272-8516, Japan.
authors.forename: Hidekatsu
authors.initials: H
authors.lastname: Yanai
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Masui
authors.forename: Reo
authors.initials: R
authors.lastname: Yoshikawa
authors.forename: Junwa
authors.initials: J
authors.lastname: Kunimatsu
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kaneko